2-AG	2-Arachidonoylglycerol
2-AGE	2-Arachidonyl glyceryl ether
AA-5HT	Arachidonoyl serotonin
ACEA	Arachidonyl-2’-chloroethylamide
ACF	Aberrant Crypt Foci
AEA	N-arachidonoylethanolamine
AI	Alkylindole synthetic
AM251	Inverse agonist at the CB1R
AM404	N-arachidonoylaminophenol
AMPK 5’	AMP-activated protein kinase
ARA-S	N-arachidonoyl serine
ATM	Ataxia–telangiectasia mutated
CaCMKKβ	Ca2+/Calmoduline-dependent kinase kinase β
CB1R	Cannabinoid1 receptor
CB2R	Cannabinoid2 receptor
CBC	Cannabichromene
CBD	Cannabidiol
CBDA	Cannabidiolic acid
CBDV	Cannabidivarin
CBG	Cannabigerol
CBN	Cannabinol
Cdk	Cyclin-dependent kinases
CFZ	Carfilzomib
COL1A1	Collagen 1A1
COX-2	Cyclooxygenase-2
CP 55,940	Synthetic cannadinoid
CRC	Colorectal cancer cells
DAGL	diacylglycerol lipase
DBT	Delayed brain tumor
EC	Endometrial cancer
ECS	Endocannabinoid system
EGFR	Epidermal growth factor receptor
EMT	Epithelial-mesenchymal transition
ER	Endoplasmic reticulum
ERK	Extracellular signal-regulated kinase
FAAH	Hydrolase fatty acid amide hydrolase
FAK	Focal adhesion kinase
FBXL5	F-box/LRR-repeat protein 5
FGF-2	Fibroblast growth factors
GC	Gastric cancer
GPR119	G protein-coupled receptor 119
GPR18	G protein-coupled receptor 18
GPR55	G protein-coupled receptor 55
GRP78	Glucose-regulated protein 78
HR	Herceptin resistant
HRAS	Harvey rat sarcoma virus
HS	Herceptin sensitive
HUVEC	Human umbilical vein endothelial cells
ID1	Inhibitor of DNA binding 1
IL-6	Interleukin 6
KRAS	Kirsten murine sarcoma virus
LPI	Lysophosphatidylinositol
LPS	Lipopolysaccharides
MAGL	Monoacylglycerol lipase
MAPK	Mitogen Activated-Protein Kinase
Met-F-AEA	2-methyl-2′-F-anandamide
MICA/B	MHC class I polypeptide–related sequence A/B
MM	Multiple myeloma
MMP2/9	Matrix metalloproteinase-2/9
mTORC1	Mammalian target of rapamycin complex 1
NAAA	N-acylethanolamine acid amide hydrolase
NADA	N-Arachidonoyl dopamine
NAPE-PLD	N-acyl phosphatidylethanolamine-specific phospholipase D
Nf-κB	Nuclear factor kappa-light-chain-enhancer of activated B cells
NK-cells	Natural Killer cells
NLRP3	NLR family pyrin domain containing 3
NMSC	Non-melanoma skin cancer
NSCLC	Non-small-cell lung cancer
O-1602	Agonist of GPR55
OA	Oleamide
OEA	Oleoylethanolamide
oGPCR	Orphan G protein-coupled receptor
OMDM-2	Cannabinoid reuptake inhibitor
PEA	Palmitoylethanolamide
PGE2	Prostaglandin E2
PKA	Protein kinase A
PLC	Phospholipase C
PPAR-α	Peroxisome proliferator-activated receptors α
PPAR-γ	Peroxisome proliferator-activated receptors γ
PRAS40	Proline-rich Akt substrate of 40 kDa
pRb	Phospho-Retinoblastoma
ROS	Reactive oxygen species
SOCS3	Suppressor of cytokine signaling 3
SPARC	Secreted protein acidic and cysteine-rich
T-ALL	T-cell acute lymphoblastic leukemia
TAMS	Tumor-associated macrophages
TCF	T Cell Factor
THC	Δ⁹-tetrahydrocannabinol
TIMP-1	Metallopeptidase inhibitor 1
TMZ	Temozolomide
TRIB3	Tribbles pseudokinase 3
TRP	Transient receptor potential
TRPV1	Transient receptor potential vanilloid type-1
TSC2	Tuberous Sclerosis Complex 2
UCM707	Cannabinoid reuptake inhibitor
URB602	[1,1’-biphenyl]-3-yl-carbamic acid
VCAM1	Vascular cell adhesion molecule 1
VDM-11	Cannabinoid reuptake inhibitor
VEGF	Vascular endothelial growth factor
VWF	Von Willebrand factor
XIAP	X-linked inhibitor apoptosis